ATLASTango Therapeutics (TNGX) earnings date: Nov 3, 2026
Tango Therapeutics (TNGX) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026. Analysts expect EPS of -$0.34.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TNGX
| Last price | $22.72 (+0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Tango Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Tango Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Tango Therapeutics. You can switch it off at any time.
Alert me before TNGX reportsFree to start. Creating an account takes under a minute.
TNGX earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.34 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +56.9% |
| Average move around a report | ±11.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Tango Therapeutics earnings history: last 5 reports
Tango Therapeutics last reported on Aug 11, 2026: EPS of -$0.37 against an estimate of -$0.32 (-15.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.32 | -$0.37 | -15.6% | Miss | -7.6% |
| May 13, 2026 | -$0.31 | -$0.32 | -3.2% | Miss | +5.8% |
| Mar 5, 2026 | -$0.33 | -$0.29 | +12.1% | Beat | +37.3% |
| Feb 19, 2026 | $0.74 | $0.78 | +5.4% | Beat | -1.7% |
| Nov 4, 2025 | -$0.07 | $0.13 | +285.7% | Beat | -6.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TNGX
See the fair value, the probability range and the earnings history of Tango Therapeutics on its ATLAS page.
Tango Therapeutics (TNGX) stock analysisPlans from €3.99 a month.
Tango Therapeutics earnings: frequently asked questions
When does Tango Therapeutics (TNGX) report earnings?
Tango Therapeutics is scheduled to report on Tuesday, November 3, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TNGX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.34 per share (USD). Estimates can change before the report.
How often does TNGX beat earnings estimates?
Of its last 5 reports with a recorded result, Tango Therapeutics beat the EPS estimate 3 times; the average surprise was +56.9%. Past results do not predict the next one.
How much does TNGX move around earnings?
Over its last 5 reports the stock moved an average of 11.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Tango Therapeutics beat earnings estimates last quarter?
Tango Therapeutics last reported on Aug 11, 2026: EPS of -$0.37 against an estimate of -$0.32 (-15.6% surprise), a miss.
How much does TNGX usually move in a day?
On a normal trading day the ATLAS model puts TNGX’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer